Former Indivior Medical Director Pleads Guilty to Misbranding Charge Brought Under Park Doctrine
September 10, 2020 at 11:02 AM EST
The former global medical director of pharmaceutical manufacturer Indivior Inc. has pleaded guilty to a misdemeanor count of introducing a misbranded drug into interstate commerce in connection with the company’s marketing of its opioid drug Suboxone Film (United States v. Baxter, No. 1:20-cr-00032-JPJ-PMS (W.D. Va.)).
The charge against Timothy Baxter was brought in a crimin... Read More
